Crossmark

Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika

Crossref DOI link: https://doi.org/10.1016/j.jcv.2016.08.096

Published Print: 2016-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Plachot, C.

Huang, C.

Vemula, R.

Wu, J.

Lee, H.J.

Anekella, B.
License Information

Text and Data Mining valid from 2016-09-01
More Information

This article is maintained by: Elsevier

Article Title: Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika

Journal Title: Journal of Clinical Virology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jcv.2016.08.096

Content Type: simple-article

Copyright: Copyright © 2016 Published by Elsevier B.V.

Document is current

Any future updates will be listed below